Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins / vaccine/toxoid preps,combo. classifier / morphine attending: chief complaint: metastatic breast cancer to the liver major surgical or invasive procedure: : extended right hepatic lobectomy; cholecystectomy; intraoperative ultrasound. history of present illness: per dr note, this a 42-year-old female who underwent a left modified radical mastectomy on for an invasive ductal carcinoma with axillary lymph node metastases that was her-2/neu positive and er/pr positive. bone scan, ct scan, and liver mri were negative for metastatic disease, and she was treated with chemotherapy and radiation. on , her ca 27.29 was 32, and on , it was noted to be elevated at 65. on , she underwent a ct scan of the chest and abdomen that demonstrated a 1.7-cm hypodense lesion in segment ii thought to represent a cyst, as well as a 2.5-cm hypodense lesion with a lower density center in segment viii of the liver. a bone scan on demonstrated no metastatic disease. on , an mri of the head demonstrated no evidence of intracranial metastases. on , a pet scan demonstrated the fdg-avid lesion in segment viii measuring 4.4 x 2.9 cm. her ca 27.29 on was elevated to 95. a liver biopsy on confirmed metastatic invasive ductal carcinoma of the breast. on , a follow-up ct scan demonstrated that the lesion was now 5.2 x 3.0 cm in size, with no other evidence of metastatic disease. she is now to undergo surgical resection. past medical history: hypertension, cardiomyopathy secondary to chemotherapy, hypothyroidism, guillain- syndrome at age 14 social history: works as occupational therapist in the program for frail elders family history: n/a physical exam: vs: 98.3, 85, 97/62, 21, 99% general: arousable, moderate pain with movement card: rrr, s1 s2 pulm: cta abd: soft, tenderness at incision extr: 1+ edema pertinent results: post op wbc-10.8# rbc-3.31* hgb-10.1* hct-29.2* mcv-88 mch-30.5 mchc-34.5 rdw-14.3 plt ct-274 pt-19.4* ptt-33.8 inr(pt)-1.8* glucose-153* urean-10 creat-0.7 na-138 k-4.6 cl-112* hco3-23 angap-8 alt-415* ast-401* alkphos-48 totbili-1.3 calcium-7.5* phos-3.7# mg-1.6 at discharge: wbc-8.3 rbc-3.02* hgb-9.2* hct-26.8* mcv-89 mch-30.3 mchc-34.2 rdw-16.7* plt ct-201 pt-15.4* ptt-32.5 inr(pt)-1.3* glucose-93 urean-15 creat-0.6 na-140 k-3.6 cl-105 hco3-26 angap-13 alt-290* ast-89* alkphos-163* totbili-1.7* calcium-8.1* phos-2.7 mg-2.1 brief hospital course: 42 y/o female with metastatic breat cancer to the liver who is taken to the or with dr for extended right hepatic lobectomy; cholecystectomy; intraoperative ultrasound. at the time of surgery she was found to have no evidence of extrahepatic metastases. intraoperative ultrasound demonstrated the lesion in segment viii with extension into segment iv, adjacent to the middle hepatic vein. there were no other lesions in the liver. further review in the or with dr ruled out the possibility of a suspicious lesion just inferior to the entrance of the hepatic veins into the vena cava in the superior portion of the caudate lobe. no other lesions in the liver were seen by ultrasound or seen grossly or were palpated. after excision of the mass, the liver was cut by pathology and the margin was approximately a 7-mm gross margin on the medial margin of the tumor. pathology shows metastatic carcinoma morphologically consistent with breast origin, present at cauterized surgical margin. please see full pathology report. the patient received it morphine and then was transitioned with adequate pain management. she was having some gi discomfort and was advanced very slowly through sips to clears. jp output that was sero-sanguinous ranged from 250 - 400 cc daily, and the drain will be left in at discharge. the patient was somnolent but arousable, sertraline was held in the immediate post op period and was then restarted at lower than her home dose. the patient was evaluated by pt and was found to be safe for home discharge. she was ambulating without assist, and was tolerating diet. the patient was given 10 liters while in the or and was started on lasix to help with diuresis. she will be sent home on a short course of lasix. the incision was c/d/i. there was some concern for drainage around the drain insertion site, this was resutured. in addition she received teaching regarding drain care and feels comfortable managing this at home. she is using acetominophen for pain management. medications on admission: exemestane 25', levothyroxine 137', lisinopril 40', lorazepam 0.5-1 qhs, lopressor 100', zofran q6-8h prn, sertraline 200', simvastatin 40', zometa 4 q6mo, calcium carbonate , vit d, mvi discharge medications: 1. metoprolol succinate 100 mg tablet sustained release 24 hr sig: one (1) tablet sustained release 24 hr po daily (daily). 2. levothyroxine 137 mcg tablet sig: one (1) tablet po daily (daily). 3. acetaminophen 325 mg tablet sig: two (2) tablet po every eight (8) hours as needed for pain: maximum 2 grams daily (6 tablets). 4. exemestane 25 mg tablet sig: one (1) tablet po once a day. 5. lisinopril 40 mg tablet sig: hold tablet po hold until notified to restart. 6. simvastatin 40 mg tablet sig: one (1) tablet po hold until notified to restart. 7. zometa 4 mg/5 ml solution sig: four (4) mg intravenous q 6 months: per your outpatient schedule. 8. multivitamin tablet sig: one (1) tablet po once a day. 9. lorazepam 0.5 mg tablet sig: 1-2 tablets po at bedtime as needed for anxiety. 10. sertraline 100 mg tablet sig: one (1) tablet po once a day: modified dose post surgery. 11. furosemide 20 mg tablet sig: one (1) tablet po bid (2 times a day). disp:*20 tablet(s)* refills:*0* 12. calcium 500 500 mg (1,250 mg) tablet sig: one (1) tablet po twice a day. 13. vitamin d 400 unit capsule sig: one (1) capsule po once a day. discharge disposition: home discharge diagnosis: metastatic breast cancer to the liver. discharge condition: stable a+o x3 ambulatory discharge instructions: please call dr office at for fever, chills, nausea, vomiting, diarrhea, increased abdominal pain, yellowing of skin or eyes, inability to take or keep down food, fluids or medications. measure and record drain output twice daily and more often as needed. bring copy of record with you to your clinic visit. monitor for large increases in the drain output, changes in the color of the drainage (green/yellow) or becomes bloody in appearance or develops a foul odor. monitor the drain insertion for redness, drainage or bleeding. keep a drain sponge around the site. do not allow the drain to hang freely. you may shower, no tub baths or swimming. place a new drain sponge around the drain insertion site daily or following shower. please weigh yourself daily and record the values. please call dr office if you note a gain or loss of 3 pounds or more and also if you note your urine output diminishes greatly. no driving if taking narcotic pain medications no heavy lifting. nothing heavier than a gallon of milk hold lisinopril and simvastatin until notified by dr these can be resumed. restart the exemestane and continue zometa on your prescribed schedule. follow up with your outpatient oncologist followup instructions: , md, phd: date/time: 2:00 echocardiogram phone: date/time: 10:00 , m.d. phone: date/time: 11:00 md ( 9 hematology/onc date/time: 1:30 pm md, procedure: cholecystectomy lobectomy of liver diagnoses: malignant neoplasm of liver, secondary unspecified pleural effusion unspecified essential hypertension unspecified acquired hypothyroidism personal history of malignant neoplasm of breast other and unspecified hyperlipidemia antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use hypovolemia mixed acid-base balance disorder secondary cardiomyopathy, unspecified 

Answer: The patient is high likely exposed to